Integra LifeSciences Holdings logo

Integra LifeSciences HoldingsNASDAQ: IART

Profile

Sector:

Healthcare

Country:

United States

IPO:

16 August 1995

Next earnings report:

04 November 2024

Last dividends:

N/A

Next dividends:

N/A
$1.56 B
-74%vs. 3y high
78%vs. sector
-36%vs. 3y high
84%vs. sector
-73%vs. 3y high
41%vs. sector
-75%vs. 3y high
23%vs. sector

Price

after hours | Fri, 01 Nov 2024 21:24:19 GMT
$20.11+$1.35(+7.22%)

Dividend

No data over the past 3 years
$418.18 M$375.78 M
$418.18 M-$12.40 M

Analysts recommendations

Institutional Ownership

IART Latest News

Integra LifeSciences to Host Third Quarter 2024 Financial Results Conference Call on November 4, 2024
globenewswire.com14 October 2024 Sentiment: POSITIVE

PRINCETON, N.J., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release third quarter 2024 financial results on Monday, November 4, 2024, prior to the market open. In conjunction with the earnings release, Integra's management team will host a conference call at 8:30 a.m. ET.

Integra LifeSciences to Present at the 2024 Wells Fargo Healthcare Conference
globenewswire.com04 September 2024 Sentiment: POSITIVE

PRINCETON, N.J., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Lea Knight, chief financial officer, will present at the Wells Fargo Healthcare conference on September 4, 2024 at 1:30pm ET.

Integra LifeSciences Continues to Make Progress on Its ESG Strategy
globenewswire.com21 August 2024 Sentiment: POSITIVE

The company published its third ESG report, underscoring its values and commitment to restoring lives The company published its third ESG report, underscoring its values and commitment to restoring lives

Integra's (IART) Q2 Earnings and Revenues Top, Margins Down
zacks.com30 July 2024 Sentiment: POSITIVE

Integra's (IART) second-quarter 2024 results reflect strong demand for its diverse portfolio of leading brands and the continued successful market adoption of CereLink.

Integra LifeSciences (IART) Q2 Earnings and Revenues Surpass Estimates
zacks.com29 July 2024 Sentiment: POSITIVE

Integra LifeSciences (IART) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of $0.62 per share. This compares to earnings of $0.71 per share a year ago.

Integra LifeSciences Reports Second Quarter 2024 Financial Results
globenewswire.com29 July 2024 Sentiment: POSITIVE

PRINCETON, N.J., July 29, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the second quarter ending June 30, 2024.

Earnings Preview: Integra LifeSciences (IART) Q2 Earnings Expected to Decline
zacks.com22 July 2024 Sentiment: NEGATIVE

Integra (IART) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Integra's (IART) New Site to Produce Recalled Tissue Products
zacks.com16 July 2024 Sentiment: POSITIVE

Integra (IART) is set to recommence the manufacturing of PriMatrix and SurgiMend at its new facility in Braintree, MA.

Integra LifeSciences Provides Updated Plans for Its Manufacturing Facility in Braintree, Massachusetts
globenewswire.com15 July 2024 Sentiment: POSITIVE

The company plans on operationalizing this new state-of-the-art facility in the first half of 2026 The company plans on operationalizing this new state-of-the-art facility in the first half of 2026

Why Is Integra (IART) Up 26% Since Last Earnings Report?
zacks.com05 June 2024 Sentiment: POSITIVE

Integra (IART) reported earnings 30 days ago. What's next for the stock?

  • 1(current)
  • 2
  • 3

What type of business is Integra LifeSciences Holdings?

Integra LifeSciences Holdings Corporation is a technology medical company whose main activity is the development, production, and sale of surgical implants and medical instruments for use in neurosurgery, limb reconstruction, orthopedics, and general surgery. The Codman Specialty Surgical segment specializes in surgical products, including a wide range of surgical implants and instruments. The Orthopedics and Tissue Technologies segment focuses on regenerative technologies for the treatment of acute and chronic wounds; tools for surgical tissue regeneration, including hernia repair, peripheral nerve repair and protection, and tendon repair. The company was founded in 1989, with its headquarters in Princeton, New Jersey.

What sector is Integra LifeSciences Holdings in?

Integra LifeSciences Holdings is in the Healthcare sector

What industry is Integra LifeSciences Holdings in?

Integra LifeSciences Holdings is in the Medical Devices industry

What country is Integra LifeSciences Holdings from?

Integra LifeSciences Holdings is headquartered in United States

When did Integra LifeSciences Holdings go public?

Integra LifeSciences Holdings initial public offering (IPO) was on 16 August 1995

What is Integra LifeSciences Holdings website?

https://www.integralife.com

Is Integra LifeSciences Holdings in the S&P 500?

No, Integra LifeSciences Holdings is not included in the S&P 500 index

Is Integra LifeSciences Holdings in the NASDAQ 100?

No, Integra LifeSciences Holdings is not included in the NASDAQ 100 index

Is Integra LifeSciences Holdings in the Dow Jones?

No, Integra LifeSciences Holdings is not included in the Dow Jones index

When was Integra LifeSciences Holdings the previous earnings report?

No data

When does Integra LifeSciences Holdings earnings report?

The next expected earnings date for Integra LifeSciences Holdings is 04 November 2024